Gastric Inhibitory Peptide (GIP),human
Sequence | YAEGTFISDYSIAMDKIHDFVNWLLAQKGKKNDWKHNITQ |
Sequence | |
Description | GIP, also known as gastric inhibitory polypeptide, or glucose-dependent insulinotropic polypeptide, is a 42-amino-acid peptide hormone synthesized in and secreted from K cells in the intestinal epithelium. There are two major GIP molecular forms in circulation, GIP (1-42) and GIP(3-42). Previous studies have demonstrated that GIP (3-42) is a degraded form of GIP (1-42) by the enzyme DPPIV. GIP secretion is primarily regulated by nutrients, especially fat. GIP exhibits potent incretin activity in rodent and human subjects. The primary action of GIP is the stimulation of glucose-dependent insulin secretion. GIP may also play a role in adipocyte biology. |
Solubility | The peptide is soluble in water. The contents of this vial have been accuray determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents. |
MW | 4983.600 |
Formula | C226H338N60O66S1 |
Purity | > 95% |
Storage | Store the peptide at -20°C. |
聯(lián)系我們
南京肽業(yè)生物科技有限公司 公司地址:江蘇省南京市六合區(qū)化學(xué)工業(yè)園區(qū)方水路158號三樓 技術(shù)支持:化工儀器網(wǎng)掃一掃 更多精彩
微信二維碼
網(wǎng)站二維碼